Cyteir Therapeutics, Inc.

CYT · NASDAQ
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$129,242$133,635$137,204$147,120
Short-Term Investments$0$0$0$0
Receivables$0$95$252$0
Inventory-$17-$95-$252$0
Other Curr. Assets$1,401$183$1,190$2,089
Total Curr. Assets$130,643$133,913$138,394$149,209
Property Plant & Equip (Net)$105$215$323$1,699
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$259$0
Tax Assets$0$0$0$0
Other NC Assets$261$260$0$2,324
Total NC Assets$366$475$582$4,023
Other Assets$0$0$0$0
Total Assets$131,009$134,388$138,976$153,232
Liabilities
Payables$508$1,339$674$1,128
Short-Term Debt$16$57$98$889
Tax Payable$0$0$0$0
Deferred Revenue-$16-$57$0$0
Other Curr. Liab.$5,445$5,183$3,189$3,298
Total Curr. Liab.$5,969$6,579$3,961$5,315
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$9$22$39$1,631
Total NC Liab.$9$22$39$1,631
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,978$6,601$4,000$6,946
Equity
Pref Stock$0$0$0$0
Common Stock$35$35$35$35
Retained Earnings-$162,536-$159,004-$150,600-$138,114
AOCI$0$0$0$0
Other Equity$287,532$286,756$285,541$284,365
Total Equity$125,031$127,787$134,976$146,286
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$131,009$134,388$138,976$153,232
Net Debt-$129,226-$133,578-$137,106-$146,231